Clinical Trial Update: The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate ursodeoxycholic acid as an adjuvant to phototherapy for neonatal indirect hyperbilirubinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperbilirubinemia

Drugs mentioned

• Ursodeoxycholic acid (UDCA) (ursodeoxycholic acid)

Snippet

Sponsor: Tishreen University Hospital | Conditions: Hyperbilirubinemia, Neonatal Indirect | NA | Status: RECRUITING